Drug Trial Radar · NCT00148733
CHIZAP: Community- and Health Facility-Based Intervention With Zinc as Adjuvant Therapy for Childhood Pneumonia
Last checked: Nov 19, 2026Latest source record: Mar 16, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,628
Actual
Start
Jan 2004
Primary completion
Jan 2008
Study completion Jan 2008
Sponsor
- Lead sponsor
- Centre For International HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Tribhuvan University, Nepal; Statens Serum Institut; All India Institute of Medical Sciences; IRD, Epidemiologie et Prevention, Montpelier, France; Society for Applied Studies
- First posted
- Sep 8, 2005
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 2 months, up to 3 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the study described is to measure the degree with which zinc given as adjunct therapy to standard antibiotic treatment during childhood pneumonia reduces the risk of treatment failure and the duration of the illness.
Conditions
- Pneumonia
Interventions
ZincDrug
Dissolvable zinc tablet 10 mg elemental zinc per day for infants 20 mg elemental zinc per day for children 12 to 35 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Risk of Treatment Failure.Time frame: Within 2 weeks after enrollment
- Non-injury Clinic Visits and Hospital Admissions After Treatment Has Been InitiatedTime frame: Within 2 weeks after enrollment
- Active and Passive Morbidity Surveillance for Six Months After the 14-day Supplementation Period is CompletedTime frame: six months
- Difference in Growth and Thymic Size Between the Treatment Groups Measured at Three and Six Months After the Zinc SupplementationTime frame: six months
- Adverse EffectsTime frame: 14 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Siddhi Memorial Hospital (SMH),Bhelukhel, Bhimsensthan
Bhaktapur, Nepal
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.